Meeting
2023 ASCO Genitourinary Cancers Symposium
Increased utilization of prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (PSMA-TRT) in African American (AA) patients at an academic medical center.
Authors
Joseph Earl Thomas
NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY
Joseph Earl Thomas , Jones T. Nauseef , Michael Philip Sun , Amie Patel , Angela Tan , Mahelia Bissassar , Jyothi Manohar , Kritika Subramanian , Koby Amankwah , Gabriela Madera , Ana M. Molina , Cora N. Sternberg , David M. Nanus , Neil Harrison Bander , Scott T. Tagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Cancer Disparities
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 36)
DOI
10.1200/JCO.2023.41.6_suppl.36
Abstract #
36
Poster Bd #
A19
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
ProstACT GLOBAL: A phase 3 study of best standard of care with and without 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer progressing despite prior treatment with a novel androgen axis drug.
First Author: Oliver Sartor
Poster
2024 ASCO Genitourinary Cancers Symposium
Safety, tolerability, and dosimetry of 177Lu-TLX591 with best standard of care in patients with PSMA-expressing metastatic castration-resistant prostate cancer (ProstAct-SELECT).
First Author: Nat Lenzo
Poster
2024 ASCO Genitourinary Cancers Symposium
The impact of perceived healthcare discrimination on health outcomes among patients with prostate cancer across racial and ethnic groups.
First Author: Daniel Sabater Minarim
Poster
2023 ASCO Genitourinary Cancers Symposium
Ga-68 PSMA-11 impacting prostate cancer management in a real-world setting: A pilot experience using the total-body PET/CT scanner.
First Author: Harshad R Kulkarni